Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

Toll-like receptors (TLRs) have first been characterized for their capacity to detect conserved microbial components like lipopolysaccharide (LPS) and double-stranded RNA, resulting in the elicitation of potent (innate) immune responses against invading pathogens. More recently, TLRs have also been...

Descripción completa

Detalles Bibliográficos
Autores principales: Vacchelli, Erika, Galluzzi, Lorenzo, Eggermont, Alexander, Fridman, Wolf Hervé, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489745/
https://www.ncbi.nlm.nih.gov/pubmed/23162757
http://dx.doi.org/10.4161/onci.20931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489745/
https://www.ncbi.nlm.nih.gov/pubmed/23162757
http://dx.doi.org/10.4161/onci.20931

Ejemplares similares